/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/order-sets/,/clinical/cckm-tools/content/order-sets/inpatient/,/clinical/cckm-tools/content/order-sets/inpatient/transplant/,

/clinical/cckm-tools/content/order-sets/inpatient/transplant/name-97912-en.cckm

20170389

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Order Sets,Inpatient,Transplant

IP - Liver Transplant - Pediatric - Postoperative [2851]

IP - Liver Transplant - Pediatric - Postoperative [2851] - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Order Sets, Inpatient, Transplant


IP - Liver Transplant - Pediatric - Postoperative [2851]
Admission Status
Level of Care (Single Response) [187485]
*An admit patient order has already been written, but the level of care at which the patient
should be placed still needs to be identified.
Place Patient on General Care [ADT0018] General Care, has already been signed. This order
will ensure that the patient is placed at the
appropriate level of care.
Place Patient on Intermediate Care (IMC)
[ADT0018]
Intermediate Care, has already been signed. This
order will ensure that the patient is placed at the
appropriate level of care.
Place Patient on Intensive Care (ICU) [ADT0018] Intensive Care, has already been signed. This order
will ensure that the patient is placed at the
appropriate level of care.
Admit to Inpatient (Single Response) [188296]
Admit To Inpatient [ADT0001] Attending:
Admitting Resident:
Requested Floor:
Service:
I certify that an inpatient stay is medically
necessary because of either an anticipated LOS >2
midnights, complexity and/or severity of illness, an
inpatient-only surgery, or a previously-authorized
inpatient stay. Rationale listed below. Yes
C - CLEAR DIAGNOSIS:
E - EVALUATIONS PLANNED:
R - RESULTS EXPECTED:
T - TREATMENTS ORDERED:
Post-Op/Phase II
Admit to Observation (Single Response)
[188297]
Admit To Observation [ADT0002] Attending:
Admitting Resident:
Requested Floor:
Service:
Post-Op/Phase II
Admit to Outpatient Short Stay (Single
Response) [188298]
Admit To Outpatient Short Stay [ADT0003] Attending:
Admitting Resident:
Requested Floor:
Service:
Post-Op/Phase II
Admission Status [106351]
Page 1 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised: 03/2017CCKM@uwhealth.org

Admit To Inpatient [ADT0001] Attending:
Admitting Resident:
Requested Floor:
Service:
I certify that an inpatient stay is medically necessary
because of either an anticipated LOS >2 midnights,
complexity and/or severity of illness, an inpatient-only
surgery, or a previously-authorized inpatient stay.
Rationale listed below. Yes
C - CLEAR DIAGNOSIS:
E - EVALUATIONS PLANNED:
R - RESULTS EXPECTED:
T - TREATMENTS ORDERED:
Post-Op/Phase II
Admit To Observation [ADT0002] Attending:
Admitting Resident:
Requested Floor:
Service:
Post-Op/Phase II
Admit To Outpatient Short Stay [ADT0003] Attending:
Admitting Resident:
Requested Floor:
Service:
Post-Op/Phase II
Admission Status [84059]
Admit To Inpatient [ADT0001] Attending:
Admitting Resident:
Requested Floor:
Service:
I certify that an inpatient stay is medically necessary
because of either an anticipated LOS >2 midnights,
complexity and/or severity of illness, an inpatient-only
surgery, or a previously-authorized inpatient stay.
Rationale listed below. Yes
C - CLEAR DIAGNOSIS:
E - EVALUATIONS PLANNED:
R - RESULTS EXPECTED:
T - TREATMENTS ORDERED:
Post-Op/Phase II
Admit To Observation [ADT0002] Attending:
Admitting Resident:
Requested Floor:
Service:
Post-Op/Phase II
Admit To Outpatient Short Stay [ADT0003] Attending:
Admitting Resident:
Requested Floor:
Service:
Post-Op/Phase II
Patient Care Orders
Vital Signs [88665]
Page 2 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

Vital Signs [NURMON0013] SEE COMMENTS, Starting today For Until specified,
Routine
Temperature Measurement Method:
Temperature Measurement Restrictions:
BP Source:
BP Location:
BP Position:
BP Restrictions:
Every 15 minutes times 4, then every hour., Post-
Op/Phase II
Activity [88667]
Activity [NURACT0008] CONTINUOUS, Routine
AD LIB:
AMBULATE:
CHAIR: 3x daily
DANGLE:
BEDREST:
RESTRICTIONS:
UPPER LEFT EXTREMITY WEIGHT BEARING:
UPPER RIGHT EXTREMITY WEIGHT BEARING:
LOWER LEFT EXTREMITY WEIGHT BEARING:
LOWER RIGHT EXTREMITY WEIGHT BEARING:
Post-Op/Phase II
Ad Lib [NURACT0008] CONTINUOUS For Until specified, Routine
AD LIB: ad lib
AMBULATE:
CHAIR:
DANGLE:
BEDREST:
RESTRICTIONS:
UPPER LEFT EXTREMITY WEIGHT BEARING:
UPPER RIGHT EXTREMITY WEIGHT BEARING:
LOWER LEFT EXTREMITY WEIGHT BEARING:
LOWER RIGHT EXTREMITY WEIGHT BEARING:
Post-Op/Phase II
Activity for Patients Less Than 1 Year of Age [88668]
Elevate Head Of Bed While Intubated
[NURACT0002]
Equal to (degrees): 15
Greater than (degrees):
Less than (degrees):
Other options:
Routine, CONTINUOUS, Starting today For Until
specified, Post-Op/Phase II
Activity for Patients Equal to or Greater Than 1 Year of Age [88669]
Elevate Head Of Bed While Intubated
[NURACT0002]
Equal to (degrees): 30
Greater than (degrees):
Less than (degrees):
Other options:
Routine, CONTINUOUS, Starting today For Until
specified, Post-Op/Phase II
Nutrition [88670]
Page 3 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

NPO Except Medications [NUT9999] EFFECTIVE NOW, Starting today, Routine
Patient Type: Adult
Diet Type: NPO
NPO: NPO except Medications
Bedside Meal Instructions:
Room Service Class:
Post-Op/Phase II
Clear Liquid Diet [NUT9999] EFFECTIVE NOW, Starting today For Until specified,
Routine
Patient Type: Pediatric
Diet Type: Diet Modifications
Diet Modifications: Liquid
Liquid: Clear Liquid
No Red or Purple Dye:
Liquid Thickness: Thin
Bedside Meal Instructions:
Room Service Class:
Post-Op/Phase II
General Diet [NUT9999] EFFECTIVE NOW, Starting today For Until specified,
Routine
Patient Type: Adult
Diet Type: General (no Modifications)
Bedside Meal Instructions:
Room Service Class:
Post-Op/Phase II
Wound Care [106352]
Wound Care [NURWND0015] CONTINUOUS, Starting today For Until specified,
Routine
Wound Type: Closed - Incision
Wound Site: Abdomen
Wound Location:
Assess Frequency:
Care Frequency: EVERY 8 HOURS
Wash With:
Irrigate/Rinse With:
Apply (Must also enter separate medication order to
obtain drug):
Primary Dressing: Gauze
Secondary Dressing:
Sterile gauze to drain sites and incision., Post-
Op/Phase II
Respiratory [88671]
Incentive Spirometry [NURTRT0018] EVERY 4 HOURS, Starting today For Until specified,
Routine, While awake., Post-Op/Phase II
Provide Manual Resuscitator at Bedside
[RT0039]
CONTINUOUS, Starting today For Until specified,
Routine, Post-Op/Phase II
Page 4 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

Mechanical Ventilation - Pediatric (Normal Lung
Protocol) [RT0028]
CONTINUOUS, Starting today For Until specified,
Routine, For ADULT patients order chlorihexidene
gluconate (PERIDEX) 0.12% soln 15 mL to swab oral
cavity 2x daily while on ventilation.
Ventilator Management: Peds Normal Lung Vent
Management Protocol
Mode:
Set Rate/Min:
Tidal Volume (mL) (4-6 mL/kg of Ideal Body Weight
for neonatal):
PEEP (cmH2O):
FiO2 (%) Titrate to Keep Sats >/= to ___%:
Pressure Support:
Pressure Control:
Wean:
Tidal Volume Multiplier: 6
P High (cmH20):
P Low (PEEP) (cmH20):
T High (sec):
T Low (T PEEP) (sec):
PS above P High (cmH2O):
PS above PEEP (cmH2O):
NAVA Level (µV):
Post-Op/Phase II
Mechanical Ventilation - Pediatric (Abnormal
Lung Protocol) [RT0028]
CONTINUOUS, Starting today For Until specified,
Routine, For ADULT patients order chlorihexidene
gluconate (PERIDEX) 0.12% soln 15 mL to swab oral
cavity 2x daily while on ventilation.
Ventilator Management: Peds Abnormal Lung Vent
Management Protocol
Mode:
Set Rate/Min:
Tidal Volume (mL) (4-6 mL/kg of Ideal Body Weight
for neonatal):
PEEP (cmH2O):
FiO2 (%) Titrate to Keep Sats >/= to ___%:
Pressure Support:
Pressure Control:
Wean:
Tidal Volume Multiplier: 6
P High (cmH20):
P Low (PEEP) (cmH20):
T High (sec):
T Low (T PEEP) (sec):
PS above P High (cmH2O):
PS above PEEP (cmH2O):
NAVA Level (µV):
Post-Op/Phase II
Oxygen Therapy [RT0032] CONTINUOUS, Starting today For Until specified,
Routine
FiO2 (%) Titrate to Keep Sats >/= to ___%:
Liter Flow:
Titrate oxygen to maintain O2 sat at (%): 92
O2 Delivery Device:
Attempt to Wean Off Oxygen? Yes
Post-Op/Phase II
Page 5 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

Pulse Oximetry [NURMON0009] CONTINUOUS, Starting today For Until specified,
Routine, Post-Op/Phase II
Intake and Output [88672]
Measure Intake And Output [NURMON0005] SEE COMMENTS, Starting today For Until specified,
Routine, Measure and record intake and output with
each occurrence., Post-Op/Phase II
Patient Monitoring [88666]
Cardio-Respiratory Monitor - Pediatric - Without
Rhythm [139420]
Cardio-Respiratory Monitor - Pediatric - Without
Rhythm [NURMON0074]
CONTINUOUS, Routine, Please complete the
Notify Provider order below, including specification
for apnea > *** seconds. If indicated, order pulse
oximetry separately.
Device Present:
Device Mode:
Device Low Rate Limit (BPM):
Notify Provider:
Post-Op/Phase II
Notify [NURCOM0001] CONTINUOUS
Provider to Notify: Provider
Notify based on:
Notify provider for apnea > 20 seconds, Post-
Op/Phase II
Measure Central Venous Pressure
[NURMON0002]
EVERY 2 HOURS, Starting today For Until specified,
Routine, Post-Op/Phase II
Measure Weight [NURMON0015] 1X DAILY, Starting today For Until specified, Routine
Weigh when? AM
Post-Op/Phase II
Measure T-Tube Output [NURTAD0020] EVERY 4 HOURS, Starting today For Until specified,
Routine
Flush with:
Post-Op/Phase II
Maintain Drain [NURTAD0003] CONTINUOUS, Starting today For Until specified,
Routine
Type: T-Tube
Drainage Options: Dependent Drainage
Post-Op/Phase II
Insert and Maintain Urinary Catheter
[NURELM0013]
CONTINUOUS, Starting today For Until specified,
Routine, To discontinue this order, enter a new order
for "Discontinue Urinary Catheter".
To modify this order, enter a new order for "Maintain
Urinary Catheter" and make the necessary changes
in the new order.
Type: Indwelling Single Lumen
Indication for Placement:
Details: To Dependent Drainage
Does this need to be inserted/placed?
Post-Op/Phase II
Maintain Drain [NURTAD0003] CONTINUOUS, Starting today For Until specified,
Routine
Type: Closed Suction (Jackson-Pratt)
Drainage Options: Bulb
Measure drain output every 4 hours (empty every 4
hours and as needed and record separately)., Post-
Op/Phase II
Non-Categorized Patient Care Orders [88673]
Page 6 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

OCCULT BLOOD, GASTRIC, POC
[HCOCBFPOC]
EVERY 2 HOURS, Starting today For Until specified,
Routine
If Conditional, What Condition?
Check gastric pH every 2 hours., Post-Op/Phase II
NG Tube Placement - Pediatric [121658]
Insert and Maintain Nasogastric Tube
[NURTAD0014]
CONTINUOUS, Routine
Options: Low, Continuous Suction
Flush with: Other (comment)
Flush Frequency: EVERY 6 HOURS
Clamp NG Tube:
Check Residual:
Does this need to be inserted/placed?
Device Status:
Irrigate nasogastric tube blue port with 5-10 mL of
air every 6 hours. Suction port with 5-10 mL
Sodium Chloride 0.9% every 6 hours.
lidocaine-oxymetazoline 3%-0.01% (PEDS) nasal
spray [785104]
Nasal, ONCE For 1 Doses
For numbing prior to feeding tube insertion. Slowly
spray the chosen nostril once, if required may
repeat x1 in opposite nostril. Angle toward back of
throat spraying the anterior nostril and wait 30-60
seconds before introducing more local anesthetic
into the nostril. Caution: Entire bottle should not be
used for insertion of tube. Discard excess solution
when procedure completed.
Post-Op/Phase II
X-RAY ABDOMEN AP VIEW (KUB) [R74000] CONDITIONAL For 3 Days, Routine
Radiology Specialty Area: GENERAL IMAGING
Current signs and symptoms?
What specific question(s) would you like answered
by this exam? Evaluate nasogastric tube placement
Relevant recent/past history?
Is patient pregnant?
If being performed remotely, where?
Last patient weight? (will auto pull in value and date
in comment):
Transport Method: Floor Determined/Entered
If Conditional, What Condition? Evaluate
nasogastric tube placement. The location of
nasogastric tube should be confirmed prior to the
instillation of fluids, medications, or feedings. Refer
to Policy 2.20 Enteral Tubes Used for Instillation of
Fluids, Medications, or Feeding
Post-Op/Phase II
Contingency Parameters [88674]
Page 7 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

Notify Provider [NURCOM0001] CONTINUOUS
Provider to Notify: Provider
If systolic blood pressure > (mmHg): ***
If systolic blood pressure < (mmHg): ***
If diastolic blood pressure > (mmHg): ***
If diastolic blood pressure < (mmHg): ***
If temperature > (C): 38.5
If temperature < (C): 36
If heart rate > (bpm): ***
If heart rate < (bpm): ***
If respiratory rate >:
If respiratory rate <:
If blood glucose > (mg/dL):
If blood glucose < (mg/dL):
If pain score >:
Pulse Oximetry < (%):
If urine output < (mL): 1 milliliter/kilogram/hour
Other: Central venous pressure less than 4 or greater
than 12 mm Hg.,Hematocrit less than 27%,INR
greater than 2.0,Potassium less than 3.5
millimole/liter,Magnesium less than 1.6
milligram/deciliter,Gastric pH less than 4.5,Prior to
administration of furosemide (LASIX)
Post-Op/Phase II
Notify BOTH ICU and Transplant Fellows
[NURCOM0001]
CONTINUOUS
Provider to Notify: Provider
If systolic blood pressure > (mmHg):
If systolic blood pressure < (mmHg):
If diastolic blood pressure > (mmHg):
If diastolic blood pressure < (mmHg):
If temperature > (C):
If temperature < (C):
If heart rate > (bpm):
If heart rate < (bpm):
If respiratory rate >:
If respiratory rate <:
If blood glucose > (mg/dL):
If blood glucose < (mg/dL):
If pain score >:
Pulse Oximetry < (%):
If urine output < (mL):
Other: Prior to infusion of blood or blood products
Post-Op/Phase II
Intravenous Therapy
IV Fluids [88676]
Note: Total IV Fluids [950004] 4 X DAILY (NOTE ACKNOWLEDGE)
Total intravenous fluids not to exceed *** mL/hour
Post-Op/Phase II
Dextrose Infusion (Single Response) [154243]
dextrose 5%-NaCl 0.2% infusion [51615] Intravenous, CONTINUOUS
Give via central venous line
Post-Op/Phase II
dextrose 5%-NaCl 0.2% with KCl 20 mEq/L
infusion [44909]
Intravenous, CONTINUOUS
Give via central venous line
Post-Op/Phase II
Page 8 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

patency line fluid in 0.9 % sodium chloride 50mL
syringe PEDS [700923]
Intraarterial, CONTINUOUS
Administer at a rate of 1mL/hour for 10kg and under
and 3mL/hour for greater than 10kg
Premedication for Needle Insertion [84317]
Lidocaine [152737]
lidocaine (LMX) 4% topical dressing kit [66882] Topical, EVERY 1 HOUR PRN, prior to needle
sticks to reduce pain. See "LMX Use Instructions"
order in Active Orders report or the Admin
Instructions for application details
FOR PATIENTS 5 Kg OR LESS: Do NOT apply to
area greater than 100 square centimeters.
(maximum 1 g/site; maximum 1 site per hour, 6
times per day).
FOR PATIENTS 5.1-10 Kg: Do NOT apply to area
greater than 100 square centimeters. (maximum 1
g/site; maximum 2 sites per hour, 6 times per day).
FOR PATIENTS GREATER THAN 10 Kg: Do NOT
apply to area greater than 200 square centimeters.
(maximum 2.5 g/site; maximum 4 sites per hour, 6
times per day).
For patients less than 1 year old do NOT leave on
longer than 1 hour. For patients 1 year or older do
NOT leave on longer than 2 hours
Post-Op/Phase II
LMX Use Instructions for Premedication Prior to
Needle Insertion [NURCOM0095]
Post-Op/Phase II
Medications - General
Analgesics - Opioids - NOTE: Order for non-intubated patients [88679]
Hydromorphone (Single Response) [152673]
HYDROmorphone PF (DILAUDID) injection -
NOTE: For patients < 40kg [800120]
0.015 mg/kg, Intravenous, EVERY 4 HOURS PRN,
pain
Severe pain. Administer when patient unable to
tolerate oral.
Post-Op/Phase II
HYDROmorphone PF (DILAUDID) injection - For
patients > 40 kg [800120]
0.8 mg, Intravenous, EVERY 4 HOURS PRN, pain
Severe pain. Administer when patient unable to
tolerate oral.
oxycodone soln - NOTE: Suggested dose 0.1
mg/kg/dose (Maximum 5 mg/dose) [45975]
0.1 mg/kg, Oral, EVERY 4 HOURS PRN, pain
For first line therapy.
NOTE: Suggested dose 0.1 mg/kg/dose (Maximum 5
mg/dose)
Post-Op/Phase II
Analgesics - Non-opioids [88680]
acetaMINOPHEN alcohol free (TYLENOL) oral
suspension - NOTE: Suggested dose 15
mg/kg/dose (Maximum 650 mg/dose) [800005]
12 mg/kg, Nasogastric Tube, EVERY 4 HOURS PRN,
pain/fever, mild to moderate pain or temperature
greater than 38.5 degrees Celsius
For first line therapy
NOTE: Suggested dose 15 mg/kg/dose (Maximum
650 mg/dose)
Post-Op/Phase II
Page 9 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

acetaMINOPHEN (TYLENOL) suppository -
NOTE: Suggested dose 15 mg/kg/dose
(Maximum 650 mg/dose) [43994]
Rectal, EVERY 4 HOURS PRN, pain/fever, mild to
moderate pain or temperature greater than 38.5
degrees Celsius.
For first line therapy. Administer if patient unable to
tolerate orally. No more than 4 grams acetaminophen
per 24 hours for adults or 15mg/kg per dose for peds
<40kg.
NOTE: Suggested dose 15 mg/kg/dose (Maximum
650 mg/dose)
Post-Op/Phase II
Anti-infectives (Single Response) [88681]
ceftriaxone (ROCEPHIN) intraVENOUS - NOTE:
Suggested dose 50 mg/kg/dose (Maximum 1
g/dose) [800027]
50 mg/kg, Intravenous, ONCE For 1 Doses
NOTE: Suggested dose 50 mg/kg/dose (Maximum 1
g/dose)
Post-Op/Phase II
clindamycin (CLEOCIN) intraVENOUS - NOTE:
Order for patients allergic to
penicillin/cephalosporins. Suggested dose 10
mg/kg/dose (Maximum 900 mg/dose) [800033]
10 mg/kg, Intravenous, EVERY 8 HOURS For 2
Doses
NOTE: Order for patients allergic to
penicillin/cephalosporins. Suggested dose 10
mg/kg/dose (Maximum 900 mg/dose)
Post-Op/Phase II
Anti-virals [88682]
ganciclovir (CYTOVENE) intraVENOUS - NOTE:
Suggested dose 5 mg/kg/dose [800188]
5 mg/kg, Intravenous, EVERY 12 HOURS
NOTE: Suggested dose 5 mg/kg/dose
Post-Op/Phase II
Note: Initiate valganciclovir [950018] PRN - NOTIFY PHARMACY WHEN NEEDED, see
Admin Instructions
Note: Initiate valganciclovir 10-15 mg/kg/dose orally
1x daily when IV ganciclovir discontinued or tolerating
oral
cytomegalovirus immune glob (CYTOGAM) bag -
NOTE: For POD #1; Suggested dose 150
mg/kg/dose [770005]
150 mg/kg, Intravenous, ONCE Starting tomorrow For
1 Doses
NOTE: For POD #1; Suggested dose 150 mg/kg/dose
cytomegalovirus immune glob (CYTOGAM) bag -
NOTE: For POD #14; Suggested dose 150
mg/kg/dose [770005]
150 mg/kg, Intravenous, ONCE Starting 4/10/17 For 1
Doses
NOTE: For POD #14; Suggested dose 150
mg/kg/dose
Post-Op/Phase II
PJP Prophylaxis (Single Response) [88683]
pentamidine (PENTAM) intraVENOUS - NOTE:
Order for patients allergic to sulfa. Suggested
dose 4 mg/kg/dose [800204]
4 mg/kg, Intravenous, EVERY 24 HOURS
NOTE: Order for patients allergic to sulfa. Suggested
dose 4 mg/kg/dose
Post-Op/Phase II
Sulfamethoxazole-trimethoprim (BACTRIM) -
Maximum Dose = 160 mg (Single Response)
[152674]
sulfamethoxazole-trimethoprim (BACTRIM)
intraVENOUS [800114]
2 mg/kg, Intravenous, 1 X DAILY
NOTE: Suggested dose 2 mg trimethoprim/kg/dose
(Maximum 160 mg/dose)
Post-Op/Phase II
sulfamethoxazole-trimethoprim (BACTRIM) 200-
40 MG/5ML susp [58784]
2 mg/kg, Oral, 1 X DAILY, Post-Op/Phase II
Candida Prophylaxis (Single Response) [88684]
Page 10 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

nystatin (MYCOSTATIN) susp - NOTE:
Suggested dose 2 mL/dose for patients less than
2 years of age [40456]
2 mL, Other, 4 X DAILY
Swab to mouth
NOTE: Order 2 mL for patients less than 2 years of
age
Post-Op/Phase II
nystatin (MYCOSTATIN) susp - NOTE: Order for
patients equal to or greater than 2 years of age
[40456]
5 mL, Swish & Swallow, 4 X DAILY
NOTE: Suggested dose 5 mL/dose for patients 2
years or older
Post-Op/Phase II
Anti-platelet (Single Response) [88685]
aspirin chew tab - NOTE for patients less than
40 kg [720014]
40.5 mg, Oral, 1 X DAILY, Post-Op/Phase II
aspirin chew tab - NOTE for patients greater than
or equal to 40 kg [720014]
81 mg, Oral, 1 X DAILY, Post-Op/Phase II
Gastric (Single Response) [88686]
ranitidine (ZANTAC) injection [800075] 1 mg/kg, Intravenous, EVERY 8 HOURS, Post-
Op/Phase II
ranitidine (ZANTAC) syrup [41612] 2 mg/kg, Oral, 2 X DAILY, Post-Op/Phase II
Flushes [88687]
UWHC Guidelines for Flushing/Locking of Venous
Access Devices in Adult & Pediatric Patients
URL: https://uconnect.wisc.edu/clinical/cckm-
tools/content/cpg/medications/name-97566-
en.cckm
heparin lock flush 10 UNIT/ML injection [75031] 1-150 units, Flush, PRN, flush/line care
Flush per VAD Guidelines
Post-Op/Phase II
Non-categorized [88688]
acetylcysteine oral soln - NOTE: Suggested dose
70 mg/kg/dose [780005]
70 mg/kg, Nasogastric Tube, 2 X DAILY
For promotion of liver detoxification/healing.
Discontinue when transferring to floor
NOTE: Suggested dose 70 mg/kg
Post-Op/Phase II
alprostadil (PROSTIN VR) 500 mcg in dextrose 5
% 250 mL bag - NOTE: Suggested dose 0.2
mcg/kg/hr [700130]
0.2 mcg/kg/hr, Intravenous, CONTINUOUS
For promotion of liver blood flow
NOTE: Suggested dose 0.2 mcg/kg/hr
Post-Op/Phase II
bacitracin ointment [49271] Topical, 2 X DAILY For 10 Days
Apply to drain sites and suture lines
Post-Op/Phase II
furosemide (LASIX) intraVENOUS - NOTE:
Suggested dose 0.5 mg/kg/dose [800046]
0.5 mg/kg, Intravenous, EVERY 6 HOURS PRN,
edema, central venous pressure greater than 12.
Notify provider before administering dose, Post-
Op/Phase II
isradipine (DYNACIRC) susp [780070] 0.1 mg/kg, Oral, EVERY 4 HOURS PRN,
hypertension - see Admin Instructions
For systolic blood pressure greater than *** mmHg or
diastolic blood pressure greater than *** mmHg
Post-Op/Phase II
ursodiol (ACTIGALL) susp - NOTE: Suggested
dose 5 mg/kg/dose (Maxium 300 mg/dose)
[780143]
5 mg/kg, Nasogastric Tube, 2 X DAILY (AT
MEALTIME)
For promotion of bile flow
NOTE: Suggested dose 5 mg/kg/dose (Maxium 300
mg/dose)
Post-Op/Phase II
Page 11 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

Note: Antithrombin III Dosing [950018] CONTINUOUS For 3 Days
When antithrombin III results are available,
pharmacist to contact Liver Transplant service to
place the antithrombin III order. Antithrombin III
dosing: [Goal AT level % (this is usually 120) - actual
AT level %) X body weight (kg)] divided by 1.4 = units
of antithrombin dose. The pharmacist will then
double check the antithrombin III dose calculation
prior to verification.
Post-Op/Phase II
Medications - Immunosupression
Steroid Taper - Note: Order All Steps [88690]
methylprednisolone sod succ. in sodium chloride
0.9% (SOLU-MEDROL) injection CUSTOM -
NOTE: Suggested dose 10 mg/kg/dose
(Minimum 125 mg/dose, maximum 500 mg/dose)
[755013]
10 mg/kg, Intravenous, ONCE Starting tomorrow For
1 Doses, for 30 Minutes
Suggested dose 10 mg/kg/dose (Minimum 125
mg/dose, maximum 500 mg/dose)
Post-Op/Phase II
methylprednisolone sod succ. in sodium chloride
0.9% (SOLU-MEDROL) injection CUSTOM -
NOTE: Suggested dose 5 mg/kg/dose (Minimum
90 mg/dose, maximum 250 mg/dose) [755013]
5 mg/kg, Intravenous, ONCE Starting 3/29/17 For 1
Doses, for 30 Minutes
Suggested dose 5 mg/kg/dose (Minimum 90
mg/dose, maximum 250 mg/dose)
Post-Op/Phase II
methylprednisolone sod succ. in sodium chloride
0.9% (SOLU-MEDROL) injection CUSTOM -
NOTE: Suggested dose 3 mg/kg/dose (Minimum
60 mg/dose, maximum 150 mg/dose) [755013]
3 mg/kg, Intravenous, ONCE Starting 3/30/17 For 1
Doses, for 30 Minutes
Suggested dose 3 mg/kg/dose (Minimum 60
mg/dose, maximum 150 mg/dose)
Post-Op/Phase II
methylprednisolone sod succ. in sodium chloride
0.9% (SOLU-MEDROL) injection CUSTOM
NOTE: Suggested dose 2 mg/kg/dose (Minimum
30 mg/dose, maximum 100 mg/dose) [755013]
2 mg/kg, Intravenous, ONCE Starting 3/31/17 For 1
Doses, for 30 Minutes
Suggested dose 2 mg/kg/dose (Minimum 30
mg/dose, maximum 100 mg/dose)
Post-Op/Phase II
methylprednisolone sod succ. in sodium chloride
0.9% (SOLU-MEDROL) injection CUSTOM -
NOTE: Suggested dose 1 mg/kg/dose (Minimum
15 mg/dose, maximum 50 mg/dose) [755013]
1 mg/kg, Intravenous, ONCE Starting 4/1/17 For 1
Doses, for 30 Minutes
Suggested dose 1 mg/kg/dose (Minimum 15
mg/dose, maximum 50 mg/dose)
Post-Op/Phase II
prednisolone (PRELONE) syrup - NOTE:
Suggested dose 1 mg/kg/dose (Minimum 5
mg/dose, maximum 30 mg/dose) [46299]
1 mg/kg, Oral, 1 X DAILY Starting 4/2/17 with First
Dose As Scheduled
NOTE: Suggested dose 1 mg/kg/dose (Minimum 5
mg/dose, maximum 30 mg/dose)
Post-Op/Phase II
Calcineurin Inhibitors (Single Response) [88691]
tacrolimus susp - NOTE: Suggested dose 0.075
mg/kg [780140]
0.075 mg/kg, Oral, EVERY 12 HOURS
NOTE: Suggested dose 0.075 mg/kg
Post-Op/Phase II
cyclosporine microemulsion (NEORAL) soln -
NOTE: Suggested dose 2-3 mg/kg/dose [780091]
Oral, 2 X DAILY
NOTE: Suggested dose 2-3 mg/kg/dose
Post-Op/Phase II
mycophenolate (CELLCEPT) intraVENOUS -
NOTE: Suggested dose 600 mg/m2 [800198]
600 mg/m2, Intravenous, 2 X DAILY
NOTE: Suggested dose 600 mg/m2
Post-Op/Phase II
Laboratory
STAT on Arrival to Pediatric ICU [88693]
Page 12 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

ELECTROLYTES [LYTE] NEXT DRAW, Starting today For 1 Occurrences,
Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
BUN [BUN] NEXT DRAW, Starting today For 1 Occurrences,
Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
CREATININE [CRET] NEXT DRAW, Starting today For 1 Occurrences,
Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
CALCIUM [CA] NEXT DRAW, Starting today For 1 Occurrences,
Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
GLUCOSE [GLU] NEXT DRAW, Starting today For 1 Occurrences,
Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
BLOOD GASES AND O2 SATURATION
[HCBGASOS]
NEXT DRAW, Starting today For 1 Occurrences,
STAT
Indicate FIO2:
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
CBC WITH DIFFERENTIAL [CBC] NEXT DRAW, Starting today For 1 Occurrences,
STAT
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
PROTHROMBIN TIME/INR [PT] NEXT DRAW, Starting today For 1 Occurrences,
STAT
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
PTT [PTT] NEXT DRAW, Starting today For 1 Occurrences,
STAT
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
Page 13 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

FIBRINOGEN [GM1320] NEXT DRAW, Starting today For 1 Occurrences,
STAT
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
ALBUMIN [ALB] NEXT DRAW, Starting today For 1 Occurrences,
STAT
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
CALCIUM, IONIZED [XICAL] NEXT DRAW, Starting today For 1 Occurrences,
STAT
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
MAGNESIUM [MAG] NEXT DRAW, Starting today For 1 Occurrences,
STAT
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
PHOSPHATE [PHOS] NEXT DRAW, Starting today For 1 Occurrences,
STAT
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Upon arrival to Pediatric ICU., Post-Op/Phase II
ANTITHROMBIN III,ACTIVITY [XAT3] NEXT DRAW For 1 Occurrences, Routine
Is the patient receiving any anticoagulant?
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
Labs Every 6 Hours Times 3 [88694]
BLOOD GASES AND O2 SATURATION
[HCBGASOS]
EVERY 6 HOURS For 3 Occurrences, Routine
Indicate FIO2:
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
HEMATOCRIT [HCT] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
PLATELET COUNT [PLT] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
Page 14 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

PROTHROMBIN TIME/INR [PT] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
PTT [PTT] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
SODIUM [NA] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
POTASSIUM [K] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
GLUCOSE [GLU] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
ALT/SGPT [ALT] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
AST/SGOT [AST] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
ALKALINE PHOSPHATASE [ALKP] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
BILIRUBIN, TOTAL [TBIL] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
BILIRUBIN, DIRECT [DBIL] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
GGT [GGT] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
Page 15 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

LD, TOTAL [LDH] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
LACTATE [GM2255] EVERY 6 HOURS For 3 Occurrences, STAT
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
AMMONIA [GM2200] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
FIBRINOGEN [GM1320] EVERY 6 HOURS For 3 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
Daily [88695]
BLOOD GASES AND O2 SATURATION
[HCBGASOS]
NEXT AM For 7 Occurrences, Routine
Indicate FIO2:
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
CBC WITH DIFFERENTIAL [CBC] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
PROTHROMBIN TIME/INR [PT] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
PTT [PTT] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
FIBRINOGEN [GM1320] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
ANTITHROMBIN III,ACTIVITY [XAT3] NEXT AM, Starting today For 7 Occurrences, Routine
Is the patient receiving any anticoagulant?
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
Page 16 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

ELECTROLYTES [LYTE] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
BUN [BUN] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
CREATININE [CRET] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
GLUCOSE [GLU] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
CALCIUM [CA] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
BILIRUBIN, TOTAL [TBIL] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
ALBUMIN [ALB] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
ALKALINE PHOSPHATASE [ALKP] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
AST/SGOT [AST] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
ALT/SGPT [ALT] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
MAGNESIUM [MAG] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
Page 17 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

PHOSPHATE [PHOS] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
GGT [GGT] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
LD, TOTAL [LDH] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
AMMONIA [GM2200] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
AMYLASE [AMYL] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
CYCLOSPORINE [XCYCA] NEXT AM For 7 Occurrences, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Trough level at 12 hour post-dose administration.,
Post-Op/Phase II
TACROLIMUS [HCTAC] 1X DAILY, Starting today For 7 Days, Routine
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Trough level at 12 hour post-dose administration,
Post-Op/Phase II
Draw Drug Level - Cyclosporine Trough Level 12
Hours Post-Dose Administration
[NURCOM0055]
ONCE For 1 Occurrences, Routine, Post-Op/Phase II
Draw Drug Level -Tacrolimus Trough Level 12
Hours Post-Dose Administration [NURCOM0055]
ONCE For 1 Occurrences, Routine, Post-Op/Phase II
Postoperative Day 3 [88696]
CULTURE, BODY FLUID WITH GRAM STAIN
[HCBFC]
ONCE, Starting 3/30/17 For 1 Occurrences, Routine,
For peritoneal, pericardial, pleural, synovial and
dialysate fluids order Culture, Body Fluid, Aer/Ana
with Gram stain and use blood culture bottles.
Indicate source if other: From pooled closed suction
(JACKSON-PRATT) drainage.
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Post-Op/Phase II
For Temperature Greater than 38 Degrees Celsius [106354]
CULTURE, BLOOD, BACTERIA/YEAST (2
SITES) [116728]
Page 18 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

.Practices for Blood Culturing Best This order equals 2 sites (4 bottles). See link below for
Best Practices for Blood Culturing URL: https://uconnect.wisc.edu/clinical/references/laboratory-
services/blood/
Lab Test Directory URL: https://uconnect.wisc.edu/clinical/tools-
resources/lab-test-directory/microbiology/name-
67798-en.labtest
CULTURE, BLOOD, BACTERIA AND YEAST
[GM4045]
NEXT DRAW, Routine, For optimum diagnosis of
sepsis, sample 3-4 sites only on the first day of a
septic episode. Cultures on subsequent days are
of minimal diagnostic value. Culture detects
bacteria, Candida and Cryptococcus. If filamentous
fungi are suspected see Culture, Blood,
Filamentous Fungi.
Patient's Active Lines:
No Active Lines Found.
If Conditional, What Condition?
CULTURE, BLOOD, BACTERIA AND YEAST
[GM4045]
NEXT DRAW, Routine, For optimum diagnosis of
sepsis, sample 3-4 sites only on the first day of a
septic episode. Cultures on subsequent days are
of minimal diagnostic value. Culture detects
bacteria, Candida and Cryptococcus. If filamentous
fungi are suspected see Culture, Blood,
Filamentous Fungi.
Patient's Active Lines:
No Active Lines Found.
If Conditional, What Condition?
CULTURE, URINE [URC] CONDITIONAL - RN COLLECT, Routine
Does patient have an indwelling urinary catheter?
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition? For temperature
greater than 38 degrees Celsius
CULTURE, BODY FLUID, AER WITH GRAM
STAIN [HCBFC]
CONDITIONAL - RN COLLECT, Routine, For
peritoneal, pericardial, pleural, synovial and dialysate
fluids order Culture, Body Fluid, Aer/Ana with Gram
stain and use blood culture bottles.
Indicate source if other: From pooled closed suction
(JACKSON-PRATT) drainage.
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition? For temperature
greater than 38 degrees Celsius.
CULTURE, BODY FLUID, AER WITH GRAM
STAIN [HCBFC]
CONDITIONAL - RN COLLECT, Routine, For
peritoneal, pericardial, pleural, synovial and dialysate
fluids order Culture, Body Fluid, Aer/Ana with Gram
stain and use blood culture bottles.
Indicate source if other: Culture from T-tube drainage.
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition? For temperature
greater than 38 degrees Celsius.
Diagnostic Tests and Imaging
Studies [88704]
Page 19 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

X-RAY CHEST AP VIEW [R71010] ONCE-RAD NEXT AVAILABLE, Starting today For 1
Occurrences, Routine
Current signs and symptoms?
What specific question(s) would you like answered by
this exam? To check placement of endotracheal tube,
nasogastric tube and central lines.
Relevant recent/past history? Status post Liver
Transplant
Is patient pregnant?
If being performed remotely, where?
Transport Method: Floor Determined/Entered
On arrival to Pediatric ICU., Post-Op/Phase II
X-RAY CHEST AP VIEW [R71010] ONCE-RAD NEXT AVAILABLE, Starting tomorrow
For 1 Occurrences, Routine
Current signs and symptoms?
What specific question(s) would you like answered by
this exam? To check placement of endotracheal tube,
nasogastric tube and central lines.
Relevant recent/past history? Status post Liver
Transplant
Is patient pregnant?
If being performed remotely, where?
Transport Method: Floor Determined/Entered
Post-Op/Phase II
US ABDOMEN COMPLETE [R76700] ONCE-RAD NEXT AVAILABLE, Starting tomorrow
For 1 Occurrences, Routine
Radiology Specialty Area: ULTRASOUND
Current signs and symptoms?
What specific question(s) would you like answered by
this exam? To assess vessel patency and flow.
Relevant recent/past history? Status post liver
transplant.
For scheduling purposes, does the patient require
general anesthesia, sedation or anxiolytics? Note:
ordering provider is responsible for prescribing oral
anxiolytics or arranging peds anesthesia / sedation
services. See reference link above.
If being performed remotely, where?
Transport Method: Floor Determined/Entered
Post-Op/Phase II
US ABDOMEN COMPLETE [R76700] ONCE-RAD NEXT AVAILABLE, Starting 3/29/17 For
1 Occurrences, Routine
Radiology Specialty Area: ULTRASOUND
Current signs and symptoms?
What specific question(s) would you like answered by
this exam? To assess vessel patency and flow.
Relevant recent/past history? Status post liver
transplant.
For scheduling purposes, does the patient require
general anesthesia, sedation or anxiolytics? Note:
ordering provider is responsible for prescribing oral
anxiolytics or arranging peds anesthesia / sedation
services. See reference link above.
If being performed remotely, where?
Transport Method: Floor Determined/Entered
Post-Op/Phase II
Page 20 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org

US ABDOMEN COMPLETE [R76700] ONCE-RAD NEXT AVAILABLE, Starting 3/30/17 For
1 Occurrences, Routine
Radiology Specialty Area: ULTRASOUND
Current signs and symptoms?
What specific question(s) would you like answered by
this exam? To assess vessel patency and flow.
Relevant recent/past history? Status post liver
transplant.
For scheduling purposes, does the patient require
general anesthesia, sedation or anxiolytics? Note:
ordering provider is responsible for prescribing oral
anxiolytics or arranging peds anesthesia / sedation
services. See reference link above.
If being performed remotely, where?
Transport Method: Floor Determined/Entered
Post-Op/Phase II
Consults [88705]
Consult UW Home Health Agency (Inpatient)
[CON0116]
ONCE, Starting today For 1 Occurrences, Routine
Reason for Consult: Central Line or Hickman
Education
Post-Op/Phase II
BestPractice
No Hospital Problems have yet been identified [107363]
Specify Hospital Problem(s) [COR0018] You will be prompted to specify a hospital problem on
signing., Post-Op/Phase II
Page 21 of 21
Printed by STRAKA, KEVIN F [KFS1] at 3/27/2017 2:39:45 PM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
03/2017CCKM@uwhealth.org